Lantern Pharma Financial Overview
Lantern Pharma's market cap is currently $37.36M. The company's EPS TTM is $-0.39; its P/E ratio is -1.99; Lantern Pharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
